Previous close | 60.50 |
Open | 60.50 |
Bid | 78.00 |
Ask | 82.50 |
Strike | 100.00 |
Expiry date | 2024-12-20 |
Day's range | 57.50 - 60.50 |
Contract range | N/A |
Volume | |
Open interest | 2 |
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
Haemonetics (HAE) Q4 revenues were driven by an uptick in the Plasma and Hospital segments.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.